David J. Moss, Chief Financial Officer, 10% Owner at Inmune Bio, Inc. (INMB), bought 7,690 shares at $6.38 ($49K) on 2024-09-12, disclosed to the SEC on 2024-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INMB | BUY | 2023-03-20 | $16K | — | Filing → |
| INMB | BUY | 2022-05-31 | $69K | — | Filing → |
| INMB | SELL | 2021-11-04 | $21K | — | Filing → |